The government recently announced that there could be a gap of 12 to 16 weeks between two doses of Covishield Vaccine. Many theories are doing rounds behind the decision to extend the gap. While some are saying that the vaccine will work better, others are saying that the decision has been taken due to the unavailability of the Serum Institute's Covishield vaccine. Top medical experts Dr. Srinath Reddy, President of Public Health Foundation of India and Dr. Chandrakant Lahariya, Epidemiologist and Public Policy and Health System Expert, join us to put light on the issue. #CNBCTV18 #COVD-19Battle #IndiaGetsVaccinated #CovishieldVaccineCNBC-TV18 is India's No.1 Business medium and the undisputed leader in business news.

The channel's benchmark coverage extends from corporate news, financial markets coverage, expert perspective on investing and management to industry verticals and beyond. CNBC-TV18 has been constantly innovating with new genres of programming that helps make business more relevant to different constituencies across India. India's most able business audience consumes CNBC-TV18 for their information & investing needs. This audience is highly diversified at one level comprising of key groups such as business leaders, professionals, retail investors, brokers and traders, intermediaries, self-employed professionals, High Net Worth individuals, students and even homemakers but shares a distinct commonality in terms of their spirit of enterprise.

(With inputs from agencies)